SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-008650
Filing Date
2018-01-11
Accepted
2018-01-11 09:01:08
Documents
7
Period of Report
2018-01-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d523601d8k.htm 8-K 42296
2 EX-3.1 d523601dex31.htm EX-3.1 52006
3 EX-3.2 d523601dex32.htm EX-3.2 6622
4 EX-4.1 d523601dex41.htm EX-4.1 38649
5 EX-10.1 d523601dex101.htm EX-10.1 231211
6 EX-10.2 d523601dex102.htm EX-10.2 48926
7 EX-99.1 d523601dex991.htm EX-99.1 12304
  Complete submission text file 0001193125-18-008650.txt   433386
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13467 | Film No.: 18522781
SIC: 8731 Services-Commercial Physical & Biological Research